Genetic study for unclassified autoinflammatory disease or AA amyloidosis
Part of Genetic & congenital, Immune system & allergy clinical trials.
This study looks for genetic causes of hard-to-diagnose autoinflammatory diseases or a related condition called AA amyloidosis. It aims to find answers for people whose condition does not fit any known type, by studying their genes and medical history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old (or if you are under 18, your parents or guardians agree to the study).
- You weigh more than 15 kg (about 33 pounds).
- You have either a type of autoinflammatory disease that hasn't been classified yet, or AA amyloidosis without a known cause.
- You are being treated in one of the study hospitals.
- You speak French and can give your permission to join the study.
- You have health insurance coverage (social security).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genes linked to autoinflammatory diseases like VEXAS syndrome. You or your family member can join by mailing in a blood or saliva sample to help researchers better understand these conditions.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study collects health information from people with adult-onset Still's disease and similar autoinflammatory conditions to better understand these diseases. By joining, you contribute to research that may lead to better care in the future.
This study looks at blood samples to better understand inflammation pathways in people with rare autoinflammatory diseases. It may help develop better tests and treatments for these conditions.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study looks at the genetic causes of cerebral amyloid angiopathy (CAA), a condition where proteins build up in small brain blood vessels. It aims to better understand the disease and may help guide future treatments.
Hear when a new Autoinflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.